United States: COVID-19 Vaccines: And Then There Were Three (Again) - Morrison & Foerster LLP

On December 11, 2020, a SARS-CoV-2 (COVID-19) vaccine developed by Pfizer and BioNTech became the first to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).